CT Scanner Market to Reach USD 11.41 Billion by 2032 as Advanced Diagnostic Imaging Gains Momentum
Market Estimation, Growth Drivers, and Opportunities
The global CT Scanner Market was valued at USD 7.69 billion in 2025 and is projected to reach nearly USD 11.41 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.8% during 2026–2032. Computed tomography (CT) scanners play a critical role in modern healthcare by producing detailed cross-sectional images that support the diagnosis and monitoring of cancer, cardiovascular conditions, neurological disorders, traumatic injuries, and other diseases.
Market growth is supported by the rising prevalence of chronic diseases, an aging population, increasing demand for early diagnosis, and the need for faster and more accurate clinical assessments. Hospitals and diagnostic imaging centers are upgrading equipment to improve diagnostic workflows and expand imaging capacity. Artificial intelligence (AI), advanced image reconstruction, photon-counting technology, and spectral imaging are creating additional opportunities by improving image detail and supporting lower-dose examinations. Emerging opportunities include specialized cardiac imaging, oncology treatment planning, emergency diagnostics, and the replacement of older scanners. However, high equipment costs, maintenance requirements, and radiation-safety considerations remain important purchasing factors.
* Get Actionable Market Insights: https://www.maximizemarketresearch.com/request-sample/9329/
United States Market: Trends and Investment in 2025
The United States remained an important market for CT imaging innovation in 2025, with manufacturers introducing technologies designed to improve diagnostic accuracy, scanning speed, and workflow efficiency. In March 2025, GE HealthCare announced its Revolution Vibe CT system, featuring advanced cardiac imaging capabilities and AI solutions. Siemens Healthineers received US Food and Drug Administration clearance for its Naeotom Alpha class of photon-counting CT scanners in March and announced the first US installation of the Naeotom Alpha.Pro at University Hospitals in Cleveland in September. In November, Philips introduced Verida, an AI-powered detector-based spectral CT system at RSNA 2025. These developments demonstrate continued investment in advanced imaging technology and highlight opportunities for healthcare providers seeking more detailed images, improved operational efficiency, and specialized diagnostic capabilities.
Market Segmentation: Largest Application and Region
By application, oncology is identified as the leading segment in the CT Scanner Market. CT imaging is widely used to detect tumors, assess the spread of cancer, support treatment planning, guide certain procedures, and monitor responses to therapy. Its ability to visualize internal structures makes it an important tool across multiple stages of cancer care. Increasing demand for timely diagnosis and precision in treatment planning supports the segment’s significance.
By region, North America dominated the market in 2025. Its position is supported by established healthcare infrastructure, the widespread use of advanced diagnostic technologies, demand for specialized imaging, and continued research and development. The presence of major medical technology manufacturers and investment in equipment modernization further support regional demand.
CT Scanner Market Key Players:
Major Contributors in the CT Scanner Market in North America:
1. NeuroLogica Corp. (Danvers, Massachusetts, USA)
2. Ryoei USA (Hollywood, Florida, USA)
3. PRIZMED IMAGING SOLUTIONS CORP. (Long Island City, New York, USA)
4. General Electric Company (Boston, Massachusetts, USA)
5. Siemens Medical Solutions USA, Inc. (Pennsylvania, USA)
6. DirectMed Parts & Service, LLC (Placentia, California, USA)
7. North Star Imaging Inc. (Rogers, Minnesota, USA)
Major Leading Player in the CT Scanner Market in Europe:
1. YXLON International (Hamburg, Germany)
Major Leading Player in the CT Scanner Market in Asia Pacific:
1. Canon Medical Systems Corporation (Otawara, Tochigi, Japan)
2. FUJIFILM Corporation (Tokyo, Japan)
3. Neusoft Corporation (Shenyang, Liaoning, China)
4. Omron (Kyoto, Japan)
5. Toshiba IT & Control Systems Corporation (Tokyo, Japan)
6. Shimadzu Seisakusho Co., Ltd. (Kyoto, Japan)
Competitive Analysis: Major Industry Participants
The MMR report identifies companies contributing to the CT Scanner Market across regional markets. It does not establish a verified global top-five ranking by market share in the publicly available overview; therefore, the following companies are discussed as prominent participants rather than as a confirmed share ranking.
GE HealthCare is advancing CT technology through AI-enabled imaging, cardiac scanning solutions, and photon-counting CT development. Its 2025 product announcements reflect investment in image quality and diagnostic efficiency.
Siemens Healthineers is expanding photon-counting CT technology, including systems designed to deliver high-resolution imaging at lower radiation doses. Its 2025 regulatory clearance and US installation demonstrate progress in clinical adoption.
Canon Medical Systems is another participant identified in the report. In March 2025, the company announced regulatory clearances for its Aquilion ONE / INSIGHT Edition CT scanner, featuring PIQE 1024 matrix and SilverBeam technologies to support advanced imaging workflows.
FUJIFILM Corporation is listed among the report’s Asia-Pacific participants. Its presence in medical imaging supports competition in diagnostic equipment and related healthcare technologies.
Neusoft Corporation, also listed in the report’s Asia-Pacific regional participants, contributes to the competitive landscape through its medical technology business. Competition among established and regional manufacturers can broaden equipment choices and encourage continued innovation.
Regional Analysis: United States, United Kingdom, Germany, France, Japan, and China
The United States benefits from advanced healthcare infrastructure, established imaging facilities, and continued investment in new CT technologies. The United Kingdom can see demand from diagnostic capacity requirements and efforts to improve access to imaging services. In Germany, a developed healthcare system and medical technology ecosystem support equipment modernization. France benefits from established hospital infrastructure and demand for diagnostic imaging in oncology and emergency care. Japan’s aging population and mature healthcare system support the use of CT scanners for disease assessment. China offers opportunities through healthcare infrastructure development and wider access to diagnostic equipment. Country-specific market-share figures and policy impacts are not quantified here because comparable figures were not verified in the report overview.
Related Reports:
Global Multimodal Imaging Market https://www.maximizemarketresearch.com/market-report/global-multimodal-imaging-market/34297/
Global Healthcare Assistive Robot Market https://www.maximizemarketresearch.com/market-report/global-healthcare-assistive-robots-market/9986/
Global Pharmaceutical Cartridges Market https://www.maximizemarketresearch.com/market-report/global-pharmaceutical-cartridges-market/31646/
Conclusion
The CT Scanner Market is positioned for continued growth as healthcare providers prioritize early diagnosis, advanced imaging, and more efficient clinical workflows. Oncology applications, North American demand, AI-assisted reconstruction, and photon-counting technology represent important areas of development. Manufacturers that combine high-quality imaging with dose optimization, dependable service, and cost-effective ownership are well placed to compete. Equipment replacement and expanding diagnostic capacity offer further opportunities for market growth through 2032.
About Maximize Market Research
Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.
Contact Maximize Market Research
MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 [email protected]